Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03609749 · ClinicalTrials.gov registry record · NA
Mindful Self-Regulation fMRI Study (MindfulPCfMRI)
A NA study, sponsored by Cambridge Health Alliance.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03609749: Clinical Trial NA study, sponsored by Cambridge Health Alliance.
NCT03609749 is a NA study that was terminated before completion, run by Cambridge Health Alliance. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03609749, a NA study, was terminated before completion, sponsored by Cambridge Health Alliance.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate changes in functional neural activation during self-regulation tasks before compared to after the Mindfulness Training for Primary Care intervention (see MINDFUL-PC (Phase 3) clinical trial). The study will also look at whether chronic disease self-management action plan initiation and successful engagement of self-report and behavioral self-regulation targets relates to the observed brain activation changes after compared to before the mindfulness intervention.
Primary Outcome
This task involves asking the participant to read about situations and imagine him/herself being self-critical or self-reassuring in these conditions.
Interventions
- BEHAVIORAL Mindfulness Training for Primary Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-01-30 |
| Est. Completion | 2020-08-01 |
| Phase | NA |
Why NCT03609749 stopped before completion
NCT03609749 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Mindfulness Training for Primary Care is the first listed.
NCT03609749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03609749 about?
NCT03609749 is a clinical study titled "Mindful Self-Regulation fMRI Study (MindfulPCfMRI)". The purpose of this study is to investigate changes in functional neural activation during self-regulation tasks before compared to after the Mindfulness Training for Primary Care intervention (see MINDFUL-PC (Phase 3) clinical trial). The study will also look at whether chronic disease self-managem...
What is the current status of trial NCT03609749?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2019-01-30. Estimated completion is 2020-08-01.
What interventions are being tested in trial NCT03609749?
The interventions under investigation include: Mindfulness Training for Primary Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT03609749?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03609749's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI